Apolipoprotein E phenotype determines the effect of alcohol on blood pressure in middle-aged men

American Journal of Hypertension

Volumn 11, Issue 11 I, 1998, Pages 1334-1343

  Kauma, Heikki ^a   Savolainen, Markku J ^a   Rantala, Asko O ^a   Lilja, Mauno ^a   Kervinen, Kari ^a   Reunanen, Antti ^b   Kesäniemi, Y Antero ^a  

^a UNIVERSITY OF OULU   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Alcohol; Blood pressure; Insulin resistance; Lipoproteins

Indexed keywords

ALCOHOL; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; GLUCOSE; INSULIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PRIORITY JOURNAL;

ADULT; ALLELES; APOLIPOPROTEINS E; BLOOD PRESSURE; ETHANOL; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PHENOTYPE;

EID: 0031738978     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00163-0     Document Type: Article

References (50)

1. Mahley R.W. Apolipoprotein E cholesterol transport protein with expanding role in cell biology . Science. 240:1988;622-630.
2. Beisiegel U., Weber W., Ihrke G., et al. The LDL-receptor-related-protein, LRP, is an apolipoprotein E-binding protein. Nature. 341:1989;162-164.
3. Utermann G., Hees M., Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature. 269:1977;604-607.
4. Zannis V.I., Just P.W., Breslow J.L. Human apolipoprotein E isoprotein subclasses are genetically determined. Am J Hum Genet. 33:1981;11-24.
5. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
6. Ehnholm C., Lukka M., Kuusi T., et al. Apolipoprotein E polymorphism in the Finnish population gene frequencies and relation to lipoprotein concentrations . J Lipid Res. 27:1986;227-235.
7. Lehtimäki T., Moilanen T., Viikari J., et al. Apolipoprotein E phenotypes in Finnish youths a cross-sectional and 6-year follow-up study . J Lipid Res. 31:1990;487-495.
8. Gerdes L.U., Klausen I.C., Sihm F. I, Aergeman O. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol. 9:1992;155-167.
9. Tiret L., de Knijff P., Menzel H.-J., et al. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations The EARS study . Arterioscler Thromb. 14:1994;1617-1624.
10. Kaprio J., Ferrell R.E., Kottke B.A., et al. Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb. 11:1991;1330-1348.
11. Uusitupa M., Sarkkinen E., Kervinen K., et al. Apolipoprotein E phenotype and blood pressure. Lancet. 343:1994;57.
12. Imazu M., Yamabe T., Yamamoto H., et al. Relationship of apolipoprotein E phenotype to the prevalence and incidence of hypertension in Japanese American men. (abst) Circulation. 90:(suppl):1994;I-503.
13. Després J.P., Verdon M.F., Moorjani S., et al. Apolipoprotein E polymorphism modifies relation of hyperinsulinemia to hypertriglyceridemia. Diabetes. 42:1993;1474-1481.
14. Kamboh M.I., Aston C.E., Ferrel R.E., Hamman R.F. Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanics whites. Atherosclerosis. 98:1993;201-211.
15. Valdez R., Howard B.V., Stern M.P., Haffner S.M. Apolipoprotein E polymorphism and insulin levels in a biethnic population. Diabetes Care. 18:1995;992-1000.
16. Kiema T.-R., Kauma H., Rantala A.O., et al. Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension. 28:1996;1070-1075.
17. Khavari K.A., Farber P.D. A profile instrument for the quantification and assessment of alcohol consumption, the Khavari alcohol test. J Stud Alcohol. 39:1978;1525-1539.
18. Grimby G. Physical activity and muscle training in the elderly. Acta Med Scand. 711:(suppl):1986;233-237.
19. Rastas M., Seppänen R., Knuts L.R., et al. Nutrient Composition of Foods. 1993;Publications of the Social Insurance Institution, Helsinki, Finland.
20. Winocour P.H., Kaluvya S., Ramaiya K., et al. Relation between insulinemia, body mass index, and lipoprotein composition in healthy, nondiabetic men and women. Arterioscler Thromb. 12:1992;393-402.
21. Menzel H.-J., Utermann G. Apolipoprotein E phenotyping from serum by western blotting. Electrophoresis. 7:1986;492.
22. Reilly S.L., Ferrell R.E., Kottke B.A., et al. The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN I. Pleiotropic effects on means and variances . Am J Hum Genet. 49:1991;1155-1166.
23. Pocock S.J. Clinical Trials. 1988;209-211 John Wiley & Sons Ltd, Chichester, England.
24. Siervogel R.M., Morrison J.A., Kelly K., et al. Familial hyper-alpha-lipoproteinemia in 26 kindreds. Clin Genet. 17:1980;13-25.
25. Sing C.F., Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet. 37:1985;268-285.
26. Boerwinkle E., Sing C.F. Bias of the contribution of single-locus effects to the variance of a quantitative trait. Am J Hum Genet. 39:1986;137-144.
27. Eichner J.E., Kuller L.H., Orchard T.J., et al. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol. 71:1993;160-165.
28. de Knijff P., Boomsma D.I., Feskens E.J.M., et al. Apolipoprotein E phenotype and blood pressure. Lancet. 343:1994;1234-1235.
29. Aromaa A, Heliövaara M, Impivaara O, et al: Health, functional limitations and need for care in Finland. Basic results from the Mini-Finland Health Survey. Publications of the Social Insurance Institution, Helsinki, Finland, AL32, 1989.
30. Klatsky A.L., Friedman G.D., Siegelaub A.B., Gérard M.J. Alcohol consumption and blood pressure. N Engl J Med. 296:1977;1194-1200.
31. Marmot M.G., Elliott P., Shipley M.J., et al. Alcohol and blood pressure the INTERSALT study . Br Med J. 308:1994;1263-1267.
32. Randin D., Vollenweider P., Tappy L., et al. Suppression of alcohol-induced hypertension by dexamethasone. N Engl J Med. 332:1995;1733-1737.
33. Eisenhofer G., Johnson R.H. Effect of ethanol ingestion on plasma vasopressin and water balance in humans. Am J Physiol. 242:1982;R522-R527.
34. Linkola J., Fyhrquist F., Nieminen M.M., et al. Renin-aldosterone axis in ethanol intoxication and hangover. Eur J Clin Invest. 6:1976;191-194.
35. Wigle D.A., Pang S.C., Sarda I.R., et al. Acute ethanol ingestion modifies the circulating plasma levels of atrial natriuretic peptide. Alcohol. 10:1993;275-280.
36. Lin R.C., Miller B.A., Kelly T.J. Concentrations of apolipoprotein AI, AII and E in plasma and lipoprotein fractions of alcoholic patients gender differences in the effects of alcohol . Hepatology. 21:1995;942-949.
37. Goode G.K., Miller J.P., Heagerty A.M. Hyperlipidaemia, hypertension, and coronary heart disease. Lancet. 345:1995;362-364.
38. Bottger A., van Lith H.A., Kren V., et al. Quantitative trait loci influencing cholesterol and phospholipid phenotypes map to chromosomes that contain genes regulating blood pressure in the spontaneously hypertensive rat. J Clin Invest. 98:1996;856-862.
39. Kesäniemi Y.A., Ehnholm C., Miettinen T.A. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest. 80:1987;578-581.
40. Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J. 113:1987;433-440.
41. Rantala M., Savolainen M.J., Kervinen K., Kesäniemi Y.A. Apolipoprotein E phenotype and diet-induced alteration in blood pressure. Am J Clin Nutr. 65:1997;543-550.
42. Vogel T., Guo N., Guy R., et al. Apolipoprotein E a potent inhibitor of endothelial and tumor cell proliferation . J Cell Biochem. 54:1994;299-308.
43. Kervinen K., Södervik H., Mäkelä J., et al. Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? Gastroenterology. 110:1996;1785-1790.
44. Weisgraber K.H., Roses A.D., Strittmatter W.J. The role of apolipoprotein E in the nervous system. Curr Opin Lipidol. 5:1994;110-116.
45. Ignatius M.J., Gebicke-Hèrter P.J., Skene J.H., et al. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci USA. 83:1986;1125-1129.
46. Strittmatter W.J., Saunders A.M., Schmechel D., et al. Apolipoprotein E high avidity binding to b-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease . Proc Natl Acad Sci USA. 90:1993;1977-1981.
47. Saunders A.M., Strittmatter W.J., Schmechel D., et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
48. Kuusisto J., Koivisto K., Kervinen K., et al. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease population based study . Br Med J. 309:1994;636-638.
49. Hallman D.M., Boerwinkle E., Saha N., et al. The apolipoprotein E polymorphism a comparison of allele frequencies and effects in nine populations . Am J Hum Genet. 49:1991;338-349.
50. Alcohol Statistical Yearbook 1994. The Finnish State Alcohol Company, Helsinki, 1995.